What the company actually pays, and whether its own cash supports it.
What stands out
Pays more per share than it earned over the last twelve months
Dividends view
Yield
1.24%Above 5Y avg (1.19%)
Annual Rate
CNY 0.25Paid unknown
Payout Ratio
147.1%High
Payback Period
57.0 yr
Last Ex-Dividend
Jun 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.57BCNY
236.20M · vs all stocks (USD)
Updated Oct 24, 2026
Trailing P/E
116.35x
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Revenue (TTM)
497.13MCNY
74.56M · vs all stocks (USD)
Updated Oct 24, 2026
Profit Margin
2.61%
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Beta
0.2550x
vs all stocks
Updated Oct 24, 2026
52-Week Change
-4.36%
vs all stocks
Updated Oct 24, 2026
Forward Annual Dividend Yield
1.24%
vs all stocks
Updated Oct 24, 2026
Market Capitalization
1.57BCNY
236.20M · vs all stocks (USD)
Updated Oct 24, 2026
Enterprise Value
1.57BCNY
235.00M · vs all stocks (USD)
Updated Oct 24, 2026
Trailing P/E
116.35x
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Price to Sales (TTM)
3.07x
vs Medical Instruments & Supplies peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 3.17×.Updated Oct 24, 2026
Price to Book (MRQ)
2.02x
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Enterprise to Revenue
3.15x
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Enterprise to EBITDA
51.67x
vs Medical Instruments & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 23.47×.Updated Oct 24, 2026
Gross Margin
42.00%
vs Medical Instruments & Supplies peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 48.3%.Updated Oct 24, 2026
Profit Margin
2.61%
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Operating Margin
9.18%
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Return on Assets (TTM)
0.22%
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Return on Equity (TTM)
1.77%
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Revenue (TTM)
497.13MCNY
74.56M · vs all stocks (USD)
Updated Oct 24, 2026
Revenue per Share (TTM)
6.82CNYUpdated Oct 24, 2026
Quarterly Revenue Growth
93.20%
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Gross Profit (TTM)
240.11MCNY
36.01M · vs all stocks (USD)
Updated Oct 24, 2026
EBITDA (TTM)
66.76MCNY
10.01M · vs all stocks (USD)
Updated Oct 24, 2026
Net Income (TTM)
12.98MCNY
1.95M · vs all stocks (USD)
Updated Oct 24, 2026
Quarterly Earnings Growth (YoY)
58.20%
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Operating Cash Flow (TTM)
76.67MCNY
11.50M · vs all stocks (USD)
Updated Oct 24, 2026
Levered Free Cash Flow (TTM)
-23.45MCNY
-3.52M · vs all stocks (USD)
Updated Oct 24, 2026
Forward Annual Dividend Rate
0.2500CNYUpdated Oct 24, 2026
Forward Annual Dividend Yield
1.24%
vs all stocks
Updated Oct 24, 2026
Trailing Annual Dividend Rate
0.2500CNYUpdated Oct 24, 2026
Trailing Annual Dividend Yield
1.23%
vs all stocks
Updated Oct 24, 2026
5-Year Average Dividend Yield
1.19%
vs all stocks
Updated Oct 24, 2026
Payout Ratio
147.12%
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Minority Interest (Equity)
18.30MCNYFY2025 · Dec 31, 2025
Revenue
441.78MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
224.26MCNYFY2025 · Dec 31, 2025
Gross Profit
217.52MCNYFY2025 · Dec 31, 2025
Operating Income
43.09MCNY
6.46M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
17.22MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-2.59MCNYFY2025 · Dec 31, 2025
Net Income
19.81MCNYFY2025 · Dec 31, 2025
EBIT
24.00MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
66.76MCNYFY2025 · Dec 31, 2025
Research & Development
60.07MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
50.80MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
7.38MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
1.14MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
6.78MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.2500CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.2500CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
74.25MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
74.25MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
19.81MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-1.25MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
40.98MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-20.98MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
105.72MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
19.81MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
9.76MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
24.36MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-12.95MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-61.96MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-132.58MCNYFY2025 · Dec 31, 2025
Sale of Investments
98.25MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-558.57KCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-96.84MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
161.11MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-217.52MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-6.83MCNYFY2025 · Dec 31, 2025
Other Financing Charges
11.89KCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-63.22MCNYFY2025 · Dec 31, 2025
Shares Outstanding
77.20MSharesUpdated Oct 24, 2026
Float Shares
44.48MSharesUpdated Oct 24, 2026
% Held by Insiders
47.49%
vs all stocks
Updated Oct 24, 2026
% Held by Institutions
5.08%
vs all stocks
Updated Oct 24, 2026
Total Cash (MRQ)
190.38MCNY
28.55M · vs all stocks (USD)
Updated Oct 24, 2026
Total Cash per Share (MRQ)
2.41CNYUpdated Oct 24, 2026
Total Debt (MRQ)
175.56MCNY
26.33M · vs all stocks (USD)
Updated Oct 24, 2026
Total Debt to Equity (MRQ)
0.2223x
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Current Ratio (MRQ)
1.48x
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Book Value per Share (MRQ)
9.77CNYUpdated Oct 24, 2026
Total Assets
1.39BCNY
207.78M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
750.37MCNYFY2025 · Dec 31, 2025
Total Liabilities
584.84MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
635.01MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
51.46MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
533.39MCNYFY2025 · Dec 31, 2025
Cash
99.88MCNYFY2025 · Dec 31, 2025
Cash Equivalents
23.12MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
123.00MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
44.86MCNYFY2025 · Dec 31, 2025
Accounts Receivable
277.78MCNYFY2025 · Dec 31, 2025
Inventory
89.83MCNYFY2025 · Dec 31, 2025
Accounts Payable
212.33MCNYFY2025 · Dec 31, 2025
Short-term Debt
149.44MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
1.00MCNYFY2025 · Dec 31, 2025
Long-term Debt
35.00MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
15.78MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
77.20MCNYFY2025 · Dec 31, 2025
Retained Earnings
287.61MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
800.54MCNY
120.07M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
22.50MCNYFY2025 · Dec 31, 2025
52-Week Low
15.30CNYUpdated Oct 24, 2026
52-Week High
32.40CNYUpdated Oct 24, 2026
52-Week Change
-4.36%
vs all stocks
Updated Oct 24, 2026
Beta
0.2550x
vs all stocks
Updated Oct 24, 2026
50-Day MA
22.03CNYUpdated Oct 24, 2026
200-Day MA
23.00CNYUpdated Oct 24, 2026
Avg 10-Day Volume
1.75MSharesUpdated Oct 24, 2026
Avg 30-Day Volume
1.54MSharesUpdated Oct 24, 2026
Diluted EPS (TTM)
0.1700CNYUpdated Oct 24, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 1.47Dividend per Share: 0.25Earnings per Share: 0.17
High gross margins eroded by operating costsNotable
Gross Margin: 0.42Profit Margin: 0.03
Financial Health
Altman Z-Score 2.47: grey zoneSignificant
Altman Z-Score: 2.47
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $236.2M, lower than 95% of all stocks globallySignificant
Market cap (USD): 236,200,502.4Global P5: 273,689,256.68
Companies that share the same coordination system — how they create, deliver, or capture value.